SELLEST PODCASTIST 🔗
pharmaphorum is one of the leading global channels for insight into the pharma and healthcare industry – and is essentially a group of passionate people who like asking excellent questions. Our podcasts offer a chance to pose some of these questions to the keenest minds in our industry to look at the big issues and opportunities facing pharma, biotech and healthcare today. With interviews and contributions from a host of industry experts and insiders, the pharmaphorum podcast is a must-listen for those who want insight into the future of health and medicine.
Värskendamise sagedus:
every 5 days
Keskmine heli pikkus:
24 minutes
Külalisintervjuud
Inglise
Ameerika Ühendriigid
364 jagu
alates 14. september 2018
episodic
AUDIENCE OF THIS PODCAST 🔗
~88.42% of listeners are from United States.
🇺🇸
US
88.42%
🇨🇦
CA
6.01%
🇵🇰
PK
2.31%
🇬🇧
GB
1.85%
🇩🇪
DE
0.46%
🇵🇭
PH
0.46%
🇨🇭
CH
0.46%
Others
0.03%
* Data source: directly measured on Listen Notes. reaalajas
VIIMANE OSA 🔗
In a new episode of the pharmaphorum podcast, Nicole Raleigh invites Mati Gill, CEO of AION Labs, back as guest.
AION Labs is a venture studio built by a coalition of pharma heavyweights, tech giants, and leading investors to develop and integrate AI technologies to redefine drug discovery and dev…
OTSI VARASEMAID OSASID
Otsi kanali pharmaphorum Podcast viimaseid osasid.
EELMISED OSAD 🔗
At ESMO 2026, Taiho Oncology presented data from Cohort C of the Phase 2 REZILIENT2 trial evaluating zipalertinib monotherapy in patients with locally advanced or metastatic non-small cell lung cancer (or NSCLC) harbouring epidermal growth factor receptor (or EGFR) exon 20 insertion mutations or ot…
As the European Society for Medical Oncology 2026 Congress commences in Madrid, pharmaphorum invited Syncromune Executive Chairman Dr Chuck Link onto the podcast for a conversation on the updated long-term overall survival data from its Phase 1 trial of SYNC-T Therapy SV-102 in patients with metast…
*This episode of the pharmaphorum podcast is brought to you in association with Klick Health*
By 2030, 1.2 billion women worldwide will be menopausal or post-menopausal - many at the peak of their working lives. Yet, menopause remains largely absent from health system planning, despite growing evi…
Even the most promising innovation still depends on strong governance, resilient operations, and confidence in sensitive data.
In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Robbie Tyrie, founder and managing director of Torridon Cyber, for a conversation on cybersecurity whe…
Industry is using AI to surface hidden patterns and accelerate decision-making in high-pressure launch environments.
In a new pharmaphorum podcast, host Nicole Raleigh speaks with Jason Smith, CTO of AI and analytics at Within3, for a conversation on data-fuelled agile launches and smarter decisio…
Bioconvergence is a multidisciplinary research and development approach that merges technologies from biology, engineering, and computation, providing solutions in medicine, food, agriculture, manufacturing, climate, and more.
In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Sh…
Artificial intelligence is dramatically transforming the landscape for every part of pharma. One area where AI is both essential to implement and important to get right is pharmacovigilance, the group concerned with monitoring and maintaining patient safety.
In today's pharmaphorum podcast, spo…
Earlier this year, the FDA released draft guidance endorsing Bayesian methods and simulation-based evidence in clinical trials in a significant shift in how regulators think about predictive medicine.
In a new pharmaphorum podcast, Dr Irina Babina, CEO of oncology R&D platform Concr, discusse…
*This episode of the pharmaphorum podcast is brought to you in association with Klick Health*
Europe continues to offer major life sciences advantages: deep scientific talent, strong clinical expertise, mature research infrastructure, and significant manufacturing capability. Indeed, biotech compa…
Vastutamatussäte: Sellele lehele manustatud taskuhäälingusaade ja kunstiteosed pärinevad pharmaphorum-lt, mis on selle omaniku omand ja ei ole seotud ettevõttega Listen Notes, Inc.
PODCASTIDE OTSINGUMOOTOR
Saate kasutada meie veebisaiti3,830,485taskuhäälingusaadete ja196,626,502osade otsimiseks inimeste, kohtade või teemade järgi.
Investeering teadmistesse annab parima tootluse, seega kuulan podcaste.
‐ Benjamin "Llamacorn" Franklin
OTSI VARASEMAID OSASID
Otsi kanali pharmaphorum Podcast viimaseid osasid.
VALI SEE PODCAST
Why to claim podcasts?
If you are a podcaster, the best way to manage your podcasts on Listen Notes is by claiming your Listen Notes
podcast pages.
It is a great, free way to engage the podcast community and increase the visibility of your podcasts.
After claiming your Listen Notes podcast pages, you will be able to:
✓
Manually refresh the RSS feed to sync up
✓
Get a verified badge (
✓
) alongside with your podcast name on Listen Notes
✓
Post kuulutused for sponsorship,
guests, co-hosts,
cross-promotion...
✓
Respond to listener comments on Listen Notes
✓
Use speech-to-text techniques to transcribe your show and
edit transcripts
✓
Improve the presence of your podcasts, e.g., self-service
taskuhäälingu tegija intervjuu...
✓
If you share your Listen Notes page and at-mention @ListenNotes
on X (formerly Twitter),
meie ametlik X-i konto (endine Twitter) will retweet to promote
your show to our followers.
Coming soon:
◯ Self-service promotion on Listen Notes
◯ Track your podcast stats on Listen
Notes, e.g., listens, page
views...
◯ Manage episodes
MUUDA
Aitäh, et aitad hoida podcastide andmebaasi ajakohasena.
